COMP <GO>
ATHE vs VERU // REVENUE GROWTH (YOY)
Alterity Therapeutics Limited (NASDAQ) VS. Veru Inc. (NASDAQ) • 15-METRIC TALLY: ATHE 1
— VERU 1
■ METRIC PARITY
LAST: $2.09 (-3.24%) • MKT CAP: $38.1M
revenue-growth
—
LAST: $2.16 (-1.37%) • MKT CAP: $36.8M
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ATHE VS. VERU)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ATHE | VERU | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 26.4 | 39.4 | -13.00 | VERU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $38.1M | $36.8M | $1.2M | ATHE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ATHE REV | VERU REV | ATHE GROSS % | VERU GROSS % | ATHE FCF | VERU FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $69.3M | — | — | — | -$30.0M |
| FY 2024 | — | $16.9M | — | 34.7% | — | -$21.8M |
| FY 2023 | — | $16.3M | — | — | — | -$88.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ATHE // BETA —
VERU // BETA —